Advertisement
Advertisement

SEPN

SEPN logo

Septerna, Inc. Common Stock

23.34
USD
Sponsored
-0.45
-1.90%
Jan 30, 16:00 UTC -5
Closed
exchange

Pre-Market

23.38

+0.04
+0.15%

SEPN Earnings Reports

Positive Surprise Ratio

SEPN beat 1 of 4 last estimates.

25%

Next Report

Date of Next Report
Mar 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$17.61M
/
-$0.27
Implied change from Q3 25 (Revenue/ EPS)
-18.06%
/
+200.00%
Implied change from Q4 24 (Revenue/ EPS)
+8207.55%
/
-57.81%

Septerna, Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, SEPN reported earnings of -0.09 USD per share (EPS) for Q3 25, missing the estimate of 0.80 USD, resulting in a -111.11% surprise. Revenue reached 21.50 million, compared to an expected 35.70 million, with a -39.79% difference. The market reacted with a -2.21% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.27 USD, with revenue projected to reach 17.61 million USD, implying an increase of 200.00% EPS, and decrease of -18.06% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Septerna, Inc. Common Stock reported EPS of -$0.09, missing estimates by -111.11%, and revenue of $21.50M, -39.79% below expectations.
The stock price moved down -2.21%, changed from $18.51 before the earnings release to $18.10 the day after.
The next earning report is scheduled for Mar 25, 2026.
Based on 9 analysts, Septerna, Inc. Common Stock is expected to report EPS of -$0.27 and revenue of $17.61M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement